ZYNOA Trademark
Serial Number: 79303063 • Registration: 6522716
ZYNOA is a trademark filed by
DA VOLTERRA
on December 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
December 2, 2020
Registration Date
October 19, 2021
Published for Opposition
August 3, 2021
Goods & Services
Pharmaceutical products for the prevention of disruption of the intestinal microbiota by antibiotics or other medicines
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 1, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 1, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 19, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 19, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Aug 15, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 3, 2021 PUBO
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2021 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2021 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Jul 10, 2021 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2021 TROA
REFUSAL PROCESSED BY IB
Jun 20, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 2, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 1, 2021 RFCR
NON-FINAL ACTION WRITTEN
May 31, 2021 CNRT
ASSIGNED TO EXAMINER
May 19, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 2, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 28, 2021 REPR
